The objective is to determine whether the hypermethylation of NPY and WIF1 is a specific biomarker of CRC in liquid biopsy by Crystal Digital PCRTM and could be used for routine diagnosis, recurrence and treatment follow-up. This evidence concerns the gene WIF1 and colorectal carcinoma.